Medications

US medical advisers vote to recommend Eli Lilly Alzheimer drug

An independent panel of US medical experts voted Monday to recommend Eli Lilly's experimental Alzheimer's drug, meaning there could soon be another treatment option available to patients with the devastating brain disorder.

Alzheimer's disease & dementia

Immunotherapy for Alzheimer's disease shows promise in mouse study

Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer's ...

Alzheimer's disease & dementia

Highly awaited Alzheimer's drug hit by delays

Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.

page 1 from 38